Skip to menu Skip to content Skip to footer

2010

Journal Article

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Wang, Xianshu, Pankratz, V. Shane, Fredericksen, Zachary, Tarrell, Robert, Karaus, Mary, McGuffog, Lesley, Pharaoh, Paul D.P., Ponder, Bruce A.J., Dunning, Alison M., Peock, Susan, Cook, Margaret, Oliver, Clare, Frost, Debra, EMBRACE, Sinilnikova, Olga M., Stoppa-Lyonnet, Dominique, Mazoyer, Sylvie, Houdayer, Claude, GEMO, Hogervorst, Frans B.L., Hooning, Maartje J., Ligtenberg, Marjolijn J., HEBON, Spurdle, Amanda, Chenevix-Trench, Georgia, kConFab, Schmutzler, Rita K., Wappenschmidt, Barbara, Engel, Christoph ... Lakhani, Sunil (2010). Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics, 19 (14), 2886-2897. doi: 10.1093/hmg/ddq174

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

2010

Journal Article

Lynch syndrome-associated breast cancers: Clinicopathologic characteristics of a case series from the colon cancer family registry

Walsh, MD, Buchanan, DD, Cummings, MC, Pearson, SA, Arnold, ST, Clendenning, M, Walters, R, McKeone, DM, Spurdle, AB, Hopper, JL, Jenkins, MA, Phillips, KD, Suthers, GK, George, J, Goldblatt, J, Muir, A, Tucker, K, Pelzer, E, Gattas, MR, Woodall, S, Parry, S, Macrae, FA, Haile, RW, Baron, JA, Potter, JD, Le Marchand, L, Bapat, B, Thibodeau, SN, Lindor, NM ... Young, JP (2010). Lynch syndrome-associated breast cancers: Clinicopathologic characteristics of a case series from the colon cancer family registry. Clinical Cancer Research, 16 (7), 2214-2224. doi: 10.1158/1078-0432.CCR-09-3058

Lynch syndrome-associated breast cancers: Clinicopathologic characteristics of a case series from the colon cancer family registry

2010

Conference Publication

Lynch syndrome-associated breast cancers: clinicopathological characteristics of a case series from the Colon CFR

Rosty, Christophe, Walsh, Michael, Cummings, Margaret, Buchanan, Daniel, Arnold, Sven, McKeone, Diane, Walters, Rhiannon, Hopper, John, Jenkins, Mark, Spurdle, Amanda, McGuckin, Michael, Lakhani, Sunil and Young, Joanne (2010). Lynch syndrome-associated breast cancers: clinicopathological characteristics of a case series from the Colon CFR. AACR 101st Annual Meeting 2010, Washington, DC, United States, 17-21 April 2010. Philadelphia, PA, United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM10-32

Lynch syndrome-associated breast cancers: clinicopathological characteristics of a case series from the Colon CFR

2010

Journal Article

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status

Flanagan, James M., Cocciardi, Sibylle, Waddell, Nic, Johnstone, Cameron N., Marsh, Anna, Henderson, Stephen, Simpson, Peter, da Silva, Leonard, kConFab Investigators, Khanna, Kumkum, Lakhani, Sunil, Boshoff, Chris, Chenevix-Trench, Georgia, Brown, Melissa, Cummings, Margaret and Edwards, Stacey (2010). DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. American Journal of Human Genetics, 86 (3), 420-433. doi: 10.1016/j.ajhg.2010.02.008

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status

2010

Conference Publication

Establishment of the Australian In Situ Hybridisation Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers into Clinical Practice

Farshid, G., Armes, J. E., Bell, R., Cummings, M., Fox, S., Francis, G., Haswell, M., Morey, A., McCue, G., Raymond, W., Robbins, P. and Bilous, M. (2010). Establishment of the Australian In Situ Hybridisation Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers into Clinical Practice. 99th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology, Washington Dc, Mar 20-26, 2010. NEW YORK: NATURE PUBLISHING GROUP.

Establishment of the Australian In Situ Hybridisation Program for the Assessment of HER2 Amplification in Breast Cancer: A Model for the Introduction of New Biomarkers into Clinical Practice

2010

Journal Article

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer

Da Silva, Leonard, Simpson, Peter T., Smart, Chanek E., Cocciardi, Sibylle, Waddell, Nic, Lane, Annette, Morrison, Brian J., Vargas, Ana Cristina, Healey, Sue, Beesley, Jonathan, Pakkiri, Pria, Parry, Suzanne, Kurniawan, Nyoman, Reid, Lynne, Keith, Patricia, Faria, Paulo, Pereira, Emilio, Skalova, Alena, Bilous, Michael, Balleine, Rosemary L., Do, Hongdo, Dobrovic, Alexander, Fox, Stephen, Franco, Marcello, Reynolds, Brent, Khanna, Kum Kum, Cummings, Margaret, Chenevix-Trench, Georgia and Lakhani, Sunil R. (2010). HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer. Breast Cancer Research, 12 (4) R46, R46-1-R46-11. doi: 10.1186/bcr2603

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer

2010

Journal Article

Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors

Arnold, Jeremy M., Choong, David Y. H., Thompson, Ella R., kConFab, Waddell, Nic, Lindeman, Geoffrey J., Visvader, Jane E., Campbell, Ian G., Chenevix-Trench, Georgia, Brown, Melissa, Cummings, Margaret and Edwards, Stacey (2010). Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors. Breast Cancer Research And Treatment, 119 (2), 491-496. doi: 10.1007/s10549-008-0269-x

Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors

2009

Journal Article

Fibroadenoma and intraduct papilloma--a common pathogenesis?

Cummings, Margaret C., Da Silva, Leonard, Papadimos, David J. and Lakhani, Sunil R. (2009). Fibroadenoma and intraduct papilloma--a common pathogenesis?. Virchows Archiv, 455 (3), 271-275. doi: 10.1007/s00428-009-0817-8

Fibroadenoma and intraduct papilloma--a common pathogenesis?

2008

Conference Publication

DNA mismatch repair deficiency in breast cancers arising in breast/colon families

Walsh, M., Cummings, M., Buchanan, D., Arnold, S., McKeone, D., Walters, R., Jass, J., Hopper, J., Jenkins, M., Spurdle, A., McGuckin, M. and Young, J. (2008). DNA mismatch repair deficiency in breast cancers arising in breast/colon families. 27th International Congress of the International-Academy-of-Pathology, Athens Greece, Oct 12-17, 2008. MALDEN: WILEY-BLACKWELL PUBLISHING, INC.

DNA mismatch repair deficiency in breast cancers arising in breast/colon families

2008

Journal Article

The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability

Houston, AM, Michael-Robinson, JM, Walsh, MD, Cummings, MC, Ryan, AE, Lincoln, D, Pandeya, N, Jass, JR, Radford-Smith, GL and O'Connell, J (2008). The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability. Human Pathology, 39 (2), 243-250. doi: 10.1016/j.humpath.2007.06.010

The "Fas counterattack" is not an active mode of tumor immune evasion in colorectal cancer with high-level microsatellite instability

2008

Journal Article

Molecular, pathologic, and clinical features of early-onset endometrial cancer: Identifying presumptive Lynch Syndrome patients

Walsh, M. D., Cummings, M. C., Buchanan, D. D., Dambacher, W. M., Arnold, S., McKeone, D., Byrnes, R., Barker, M. A., Leggett, B. A., Gattas, M., Jass, J. R., Spurdle, A. B., Young, J. and Obermair, A. (2008). Molecular, pathologic, and clinical features of early-onset endometrial cancer: Identifying presumptive Lynch Syndrome patients. Clinical Cancer Research, 14 (6), 1692-1700. doi: 10.1158/1078-0432.CCR-07-1849

Molecular, pathologic, and clinical features of early-onset endometrial cancer: Identifying presumptive Lynch Syndrome patients

2008

Journal Article

Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53 and p16 immunostaining in cutaneous melanomas

Richmond-Sinclair, N.M., Lee, E., Cummings, M.C., Williamson, R., Muller, H.K., Green, A.C., Hayward, N.K. and Whiteman, D.C. (2008). Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53 and p16 immunostaining in cutaneous melanomas. Melanoma research, 18 (5), 336-345. doi: 10.1097/CMR.0b013e32830d8329

Histologic and epidemiologic correlates of P-MAPK, Brn-2, pRb, p53 and p16 immunostaining in cutaneous melanomas

2007

Journal Article

Genome-wide association study identifies novel breast cancer susceptibility loci

Easton, Douglas F., Pooley, Karen A., Dunning, Alison M., Pharoah, Paul D. P., Thompson, Deborah, Ballinger, Dennis G., Struewing, Jeffery P., Morrison, Jonathan, Field, Helen, Luben, Robert, Wareham, Nicholas, Ahmed, Shahana, Healey, Catherine S., Bowman, Richard, SEARCH collaborators, Meyer, Kerstin B., Haiman, Christopher A., Kolonel, Laurence K., Henderson, Brian E., Marchand, Loic Le, Brennan, Paul, Sangrajrang, Suleeporn, Gaborieau, Valerie, Odefrey, Fabrice, Shen, Chen-Yang, Wu, Pei-Ei, Wang, Hui-Chun, Eccles Diana, Evans, D. Gareth ... Ward, Robyn (2007). Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 447 (7148), 1087-1093. doi: 10.1038/nature05887

Genome-wide association study identifies novel breast cancer susceptibility loci

2006

Journal Article

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival

Herath, Nirmitha I., Spanevello, Mark D., Sabesan, Sabe, Newton, Tanya, Cummings, Margaret, Duffy, Shannon, Lincoln, Douglas, Boyle, Glen, Parsons, Peter G. and Boyd, Andrew W. (2006). Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival. BMC Cancer, 6 (144) 144, 144. doi: 10.1186/1471-2407-6-144

Over-expression of Eph and ephrin genes in advanced ovarian cancer: ephrin gene expression correlates with shortened survival

2006

Journal Article

Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance

Chenevix-Trench, Georgia, Healey, Sue, Lakhani, Sunil, Waring, Paul, Cummings, Margaret, Brinkworth, Ross, Deffenbaugh, Amie M., Burbidge, Lynn Anne, Pruss, Dmitry, Judkins, Thad, Scholl, Tom, Bekessy, Anna, Marsh, Anna, Lovelock, Paul, Wong, Ming, Tesoriero, Andrea, Renard, Helene, Southey, Melissa, Hopper, John L., Yannoukakos, Koulis, Brown, Melissa, kConFab Investigators, Easton, Douglas, Tavtigian, Sean V., Goldgar, David and Spurdle, Amanda B. (2006). Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance. Cancer Research, 66 (4), 2019-2027. doi: 10.1158/0008-5472.CAN-05-3546

Genetic and Histopathologic Evaluation of BRCA1 and BRCA2 DNA Sequence Variance of Unknown Clinical Significance

2006

Conference Publication

DNA mismatch repair deficiency in early-onset endometrial carcinomas

Walsh, M, Young, J, Cummings, M, Buchanan, D, Barker, M, Gattas, M, Leggett, B, Jeremy, J, Spurdle, A and Obermair, A (2006). DNA mismatch repair deficiency in early-onset endometrial carcinomas. 26th International Congress of the International-Academy-of-Pathology, Montreal Canada, Sep 16-21, 2006. NEW YORK: NATURE PUBLISHING GROUP.

DNA mismatch repair deficiency in early-onset endometrial carcinomas

2006

Journal Article

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing

Farshid, G, Balleine, RL, Cummings, M, Waring, P and kConFab Grp (2006). Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing. American Journal of Surgical Pathology, 30 (11), 1357-1366. doi: 10.1097/01.pas.0000213273.22844.1a

Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing

2006

Journal Article

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry

Bilous, Michael, Morey, Adrienne, Armes, Jane, Cummings, Margaret and Francis, Glenn (2006). Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry. Pathology, 38 (2), 120-124. doi: 10.1080/00313020600561518

Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry

2006

Journal Article

Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer

Newton, Tanya R., Parsons, Peter G., Lincoln, Douglas J., Cummings, Margaret C., Wyld, David K., Webb, Penelope M., Green, Adele C. and Boyle, Glen M. (2006). Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer. International Journal of Cancer, 119 (4), 875-883. doi: 10.1002/ijc.21823

Expression profiling correlates with treatment response in women with advanced serous epithelial ovarian cancer

2005

Journal Article

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma

Arnold, J. M., Huggard, P. R., Cummings, M., Ramm, G. A. and Chenevix-Trench, G. (2005). Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma. British Journal of Cancer, 92 (11), 2024-2031. doi: 10.1038/sj.bjc.6602596

Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma